Patient Capital Management, LLC
13F Reported Value
ⓘ$3.1B
incl. option notional
Equity Holdings
ⓘ$3.0B
Option Notional
ⓘ$40.9M
$0 puts / $40.9M calls
Holdings
40
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Patient Capital Management, LLC disclosed 40 positions worth $3.1B in its Form 13F-HR for Q2 2026 — $3.0B in common stock plus $40.9M of put/call option positions (reported at underlying notional value, not premium at risk), led by $RPRX (Royalty Pharma plc) at 6.7% of the equity portfolio, followed by $C and $GOOG. During the quarter the fund opened 2 new positions and exited 2 — including a new stake in $GPN and a full exit from $IBIT. The portfolio is most concentrated in Healthcare (22.6% of disclosed assets). All figures are sourced directly from Patient Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1854794.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$201.8M3,598,808 sh - 65.0#507
Quality
$196.4M1,403,477 sh - 78.2#57
Quality
$187.9M525,750 sh - 62.7
Quality
$182.0M437,773 sh - 68.7
Quality
$162.3M681,047 sh - 85.9
Quality
$142.0M709,587 sh - 59.4
Quality
$127.8M1,235,505 sh - $127.3M6,029,642 sh
- 49.0
Quality
$123.3M7,136,669 sh - 64.4
Quality
$116.3M6,080,678 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $201.8M | 3,598,808 | |
| 65.0#507 | $196.4M | 1,403,477 | |
| 78.2#57 | $187.9M | 525,750 | |
| 62.7 | $182.0M | 437,773 | |
| 68.7 | $162.3M | 681,047 | |
| 85.9 | $142.0M | 709,587 | |
| 59.4 | $127.8M | 1,235,505 | |
| — | $127.3M | 6,029,642 | |
| 49.0 | $123.3M | 7,136,669 | |
| 64.4 | $116.3M | 6,080,678 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Patient Capital Management, LLC's 40 positions.
Showing top 10 of 40 holdings.
Sector Allocation
Healthcare
$681.4M
Technology
$584.0M
Financials
$536.4M
Consumer Discretionary
$462.5M
Industrials
$432.1M
Energy
$195.5M
Other
$112.8M
Communication Services
$4.9M
Full Holdings — Patient Capital Management, LLC (Q2 2026)
All 40 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Royalty Pharma plc | $201.8M | 6.7% | -1% | — | |
| 2 | CITIGROUP INC | $196.4M | 6.5% | -1% | 65 | |
| 3 | Alphabet Inc. | $187.9M | 6.2% | -2% | 78.2 | |
| 4 | UNITEDHEALTH GROUP INC | $182.0M | 6.0% | +0% | 62.7 | |
| 5 | AMAZON COM INC | $162.3M | 5.4% | +4% | 68.7 | |
| 6 | NVIDIA CORP | $142.0M | 4.7% | -0% | 85.9 | |
| 7 | CVS HEALTH Corp | $127.8M | 4.3% | -9% | 59.4 | |
| 8 | Norwegian Cruise Line Holdings Ltd. | $127.3M | 4.2% | +5% | — | |
| 9 | QXO, Inc. | $123.3M | 4.1% | +5% | 49 | |
| 10 | Energy Transfer LP | $116.3M | 3.9% | -0% | 64.4 | |
| 11 | — | PEOPLE INC - COM NEW | $112.0M | 3.7% | -10% | — |
| 12 | PRECIGEN, INC. | $108.5M | 3.6% | +7% | 29.6 | |
| 13 | United Airlines Holdings, Inc. | $99.5M | 3.3% | -0% | 60.8 | |
| 14 | Crocs, Inc. | $96.4M | 3.2% | -5% | 58 | |
| 15 | Meta Platforms, Inc. | $96.2M | 3.2% | -0% | 79.6 | |
| 16 | Chime Financial, Inc. | $83.6M | 2.8% | +42% | 53.5 | |
| 17 | ADOBE INC. | $74.0M | 2.5% | +21% | 77.6 | |
| 18 | SEADRILL Ltd | $73.9M | 2.5% | -9% | — | |
| 19 | GLOBAL PAYMENTS INC | $68.4M | 2.3% | NEW | 47 | |
| 20 | Coinbase Global, Inc. | $67.5M | 2.2% | +7% | 44.8 | |
| 21 | Fidelity Wise Origin Bitcoin Fund | $62.2M | 2.1% | +244% | — | |
| 22 | BIOGEN INC. | $61.3M | 2.0% | -25% | 64.7 | |
| 23 | ILLUMINA, INC. | $60.7M | 2.0% | -37% | 60.4 | |
| 24 | General Motors Co | $48.7M | 1.6% | -15% | 54.3 | |
| 25 | UBS Group AG | $47.3M | 1.6% | -23% | — | |
| 26 | FISERV INC | $46.8M | 1.6% | -2% | 60.7 | |
| 27 | Expedia Group, Inc. | $42.9M | 1.4% | +0% | 71.1 | |
| 28 | OneMain Holdings, Inc. | $42.8M | 1.4% | -10% | 66.4 | |
| 29 | BIOGEN INC. | $40.9M | — | +9900% | 64.7 | |
| 30 | DELTA AIR LINES, INC. | $40.4M | 1.3% | -22% | 57.5 | |
| 31 | JD.com, Inc. | $35.1M | 1.2% | -2% | — | |
| 32 | SoFi Technologies, Inc. | $27.0M | 0.9% | +14% | 62.4 | |
| 33 | Tempus AI, Inc. | $23.2M | 0.8% | -9% | 41.2 | |
| 34 | JPMORGAN CHASE & CO | $9.6M | 0.3% | -0% | 70.7 | |
| 35 | Genius Sports Ltd | $4.9M | 0.2% | NEW | — | |
| 36 | Noble Corp plc | $3.7M | 0.1% | -93% | — | |
| 37 | Dave & Buster's Entertainment, Inc. | $2.3M | 0.1% | -82% | 37.8 | |
| 38 | APA Corp | $1.6M | 0.1% | +0% | — | |
| 39 | LENNAR CORP /NEW/ | $1.1M | 0.0% | +0% | 47.2 | |
| 40 | SPDR S&P 500 ETF TRUST | $791,601 | 0.0% | -5% | — |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Patient Capital Management, LLC including:
Track Patient Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Patient Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Patient Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Patient Capital Management, LLC (SEC CIK: 1854794), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Patient Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.